Showing results (1-10 of 564) with videos related to
Sort By:
Pageof 57
Seminars in Oncology|March 14, 2003
Molecular and cellular biology of small cell lung cancerMartin Sattler, Ravi SalgiaLeukemia Research|March 24, 2004
Targeting c-Kit mutations: basic science to novel therapiesMartin Sattler, Ravi SalgiaCurrent Oncology Reports|February 10, 2007
c-Met and hepatocyte growth factor: potential as novel targets in cancer therapyMartin Sattler, Ravi SalgiaScience Translational Medicine|October 25, 2013
A new hope for precision medicineRavi Salgia, Martin SattlerUpdate on Cancer Therapeutics|April 7, 2010
The MET axis as a therapeutic targetMartin Sattler, Ravi SalgiaCell Reports. Medicine|February 28, 2025
The expanding role of the receptor tyrosine kinase MET as a therapeutic target in non-small cell lung cancerMartin Sattler, Ravi SalgiaThescientificworldjournal|October 7, 2008
EGFR-targeted therapeutics: focus on SCCHN and NSCLCMartin Sattler, Oyewale Abidoye, Ravi SalgiaTrends in Cancer|February 8, 2023
Precision oncology provides opportunities for targeting KRAS-inhibitor resistanceMartin Sattler, Atish Mohanty, Prakash Kulkarni, et al.Frontiers in Pharmacology|January 24, 2022
Novel Therapeutic Targets and Immune Dysfunction in Malignant Pleural MesotheliomaMoshe Lapidot, Srinivas Vinod Saladi, Ravi Salgia, et al.Cell Reports. Medicine|February 1, 2021
The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC)Ravi Salgia, Rebecca Pharaon, Isa Mambetsariev, et al.Pageof 57